Development of theory on intestinal dysfunction in the XXI century


Cite item

Full Text

References

  1. Саркисов Д. С. Существуют ли так называемые функциональные болезни? Клин. мед. 1994; 2: 71-74.
  2. Drossman D. A. Functional gastrointestinal disorders and the Rome III Process. Gastroenterology 2006; 130 (5): 1377-1390.
  3. Gonsalkorale W. M., Perrey C., Pravica V. et al. Interleukin 10 genotypes in irritable bowel syndrome (evidence for an inflammatory component?). Gut 2003; 52: 91-93.
  4. Yeo A., Boyd P., Lumsden S. et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004; 53: 1452-1458.
  5. Kim H. J., Camilleri M., Carlson P. J. et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004; 53: 829-837.
  6. Caspi A., Sugden K., Moffitt T. E. et al. Influence of life stress on depression (moderation by a polymorphism in the 5-HTT gene 57). Science 2003; 301: 386-389.
  7. Levy R. L., Jones K. R., Whitehead W. E. et al. Irritable bowel syndrome in twins (heredity and social learning both contribute to etiology). Gastroenterology 2001; 121: 799-804.
  8. Drossman D. A. Functional G1 disorders (what?s in a name?). Gastroenterology 2005; 128: 1771-1772.
  9. Murray C. D., Flynn J., Ratcliffe L.et al. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004; 127: 1695-1703.
  10. Parkman H. P., Hasler W. L., Fisher R. S. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 1592-1622.
  11. Drossman D. A., Camilleri M., Mayer E. A., Whitehead W. E. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-2131.
  12. Drossman D. A. Brain imaging and its implications for studying centrally targeted treatments in IBS (a primer for gastroenterologists). Gut 2005; 54: 569-573.
  13. Delgado-Aros S., Camilleri M. Visceral hypersensitivity 2. J. Clin. Gastroenterol. 2005; 39: 194-203.
  14. Dunlop S. P., Coleman N. S., Blackshaw E. et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 2005; 3: 349-357.
  15. Dunlop S. P., Jenkins D., Neal K. R., Spiller R. C. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfections IBS. Gastroenterology 2003; 125: 1651-1659.
  16. Gwee K. A., Collins S. M., Read N. W. et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52: 523-526.
  17. Парфенов А. И., Ручкина И. Н., Екисенина Н. И. Антибактериальная терапия при синдроме раздраженного кишечника. Клин. мед. 1996; 5: 41-43.
  18. Scarpellini E., Cazzato A., Lauritano C. et al. Probiotics: which and when? Dig. Dis. Sci. 2008; 26 (2): 175-182.
  19. Бондаренко В. М., Мацулевич Т. В., Парфенов А. И., Лыкова Е. А. Синдром избыточного бактериального роста в тонкой кишке. Экспер. и клин. гастроэнтерол. 2005; 6: 51-57.
  20. Парфенов А. И., Ручкина И. Н., Оробей Ю. А., Быкова С. В. Эффективность Римских критериев II в диагностике СРК. Тер. арх. 2004; 4: 51-54.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies